Viatris VTRS
NASDAQ VTRS
$16.44 -0.17 (-0.99%)
As of: Sep 9, 2026 · 3:06 PM EDT

Viatris (VTRS) Inventory (2019 - 2026)

Viatris (VTRS) posted Inventory of $3.9 billion for Q2 2026, little changed on a QoQ basis from $3.9 billion in Q1 2026, and down 7.76% year-over-year from $4.3 billion in Q2 2025.

Analysis

Viatris (VTRS) Inventory (2019 - 2026) Analysis & Trends

Viatris has reported Inventory for 8 years, with the latest figure at $3.9 billion in Q2 2026.

  • On a quarterly basis, Inventory fell 7.76% year-over-year to $3.9 billion in Q2 2026; TTM through Jun 2026 was $3.9 billion, a 7.76% decrease from a year earlier, with the FY2025 full-year figure at $4.0 billion, up 3.76% from the prior year.
  • Inventory was $3.9 billion for Q2 2026 at Viatris, roughly flat from $3.9 billion in the prior quarter.
  • The five-year high for Inventory was $4.3 billion in Q2 2025, with the low at $3.4 billion in Q3 2022.
  • Average Inventory over 5 years is $3.8 billion, with a median of $3.8 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Inventory retreated 23.17% in 2022, then advanced 11.24% in 2024.
  • Over 5 years, Inventory stood at $3.5 billion in 2022, then retreated by 1.41% to $3.5 billion in 2023, then rose by 11.08% to $3.9 billion in 2024, then advanced by 3.76% to $4.0 billion in 2025, then decreased by 1.65% to $3.9 billion in 2026.
  • The last three Inventory figures came in at $3.9 billion (Q2 2026), $3.9 billion (Q1 2026), and $4.0 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn 3.22 Bn
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn 3.93 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 850.02 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn 677.95 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 1.60 Bn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn 226.55 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 143.15 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 179.91 Mn
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn -
10 RedHill Biopharma 178.79 Mn 178.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.93 Bn
Mar 31, 2026 3.93 Bn
Dec 31, 2025 4.00 Bn
Sep 30, 2025 4.11 Bn
Jun 30, 2025 4.26 Bn
Mar 31, 2025 4.10 Bn
Dec 31, 2024 3.85 Bn
Sep 30, 2024 4.08 Bn
Jun 30, 2024 3.94 Bn
Mar 31, 2024 3.82 Bn
Dec 31, 2023 3.47 Bn
Sep 30, 2023 3.67 Bn
Jun 30, 2023 3.64 Bn
Mar 31, 2023 3.66 Bn
Dec 31, 2022 3.52 Bn
Sep 30, 2022 3.38 Bn
Jun 30, 2022 3.61 Bn
Mar 31, 2022 3.80 Bn
Dec 31, 2021 3.98 Bn
Sep 30, 2021 4.08 Bn